Coronary Artery Bypass Graft Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

Description

Persistence Market Research has recently published an in-depth analysis of the global Coronary Artery Bypass Graft Market, offering a comprehensive overview of key market dynamics, growth drivers, challenges, and emerging trends. This report provides valuable insights into the Coronary Artery Bypass Graft Market, presenting exclusive data and statistics that forecast the market's growth trajectory from 2023 to 2030.

The global market for Coronary Artery Bypass Graft is anticipated to experience a compound annual growth rate (CAGR) of 2.3%, leading to a rise from US$17.61 billion in 2023 to reach US$20.65 billion by the conclusion of 2030.

Key Insights:

Coronary Artery Bypass Graft Market Size (2023E): US$17.61 Bn
Projected Market Value (2030F): US$20.65 Bn
Global Market Growth Rate (CAGR 2023 to 2030): 2.3%
Historical Market Growth Rate (CAGR 2018 to 2022): 1.2%

Coronary Artery Bypass Graft Market- Report Scope:

Coronary Artery Bypass Graft (CABG) is a vital medical procedure for treating coronary artery disease. It involves rerouting blood flow around blocked arteries using grafts from the patient's limb or chest. CABG aims to reduce heart attack risk, alleviate chest pain, and improve heart function, benefiting patients with severe coronary artery disease. Key drivers of the global CABG market include the growing incidence of coronary artery disease, aging populations, technological advancements, improved healthcare infrastructure in emerging nations, increased awareness of CABG benefits, and the adoption of minimally invasive techniques.

Market Growth Drivers:

The global Coronary Artery Bypass Graft (CABG) market is driven by the increasing prevalence of coronary artery disease (CAD) globally. Lifestyle changes, such as sedentary behavior, unhealthy eating habits, and rising obesity rates, contribute to atherosclerotic lesions in coronary arteries, leading to CAD. The aging global population also amplifies the demand for CABG procedures due to the higher likelihood of developing cardiovascular diseases with age. However, the market faces challenges from the growing popularity of alternative treatments, such as minimally invasive techniques and advancements in interventional cardiology. These alternatives offer benefits like shorter recovery periods and fewer complications, posing a significant obstacle to traditional CABG procedures.

Market Restraints:

A significant restraint for the global Coronary Artery Bypass Graft (CABG) market is the escalating financial strain, particularly in low and middle-income nations. Despite the effectiveness of CABG in treating coronary artery disease, the associated costs of surgery, postoperative care, and rehabilitation pose financial burdens for many individuals. Economic restrictions in specific regions limit access to CABG procedures, hindering market expansion. The financial burden includes both direct and indirect costs, leading to challenges in allocating sufficient funds for cardiovascular interventions in resource-constrained contexts, resulting in disparities in CABG service availability.

Market Opportunities:

The global Coronary Artery Bypass Graft (CABG) market benefits from opportunities in the progress of robotic-assisted surgery technology. Robotic-assisted CABG offers advantages in patient outcomes, precision, and dexterity, transforming traditional procedures. Surgeons can perform meticulous maneuvers, allowing for delicate tasks during bypass grafting. This aligns with the trend toward minimally invasive methods, providing benefits such as shorter incisions, reduced trauma, and faster recovery. The implementation of robotic-assisted CABG expands the patient pool, including those previously ineligible for open-heart surgery, making it a desirable option and presenting a unique opportunity for market growth.

Key Questions Answered in the Report:

What are the key factors driving the growth of the Coronary Artery Bypass Graft Market?
Which industry verticals are driving the demand for Coronary Artery Bypass Graft?
How are technological advancements reshaping the competitive landscape of the Coronary Artery Bypass Graft Market?
Who are the leading players in the global Coronary Artery Bypass Graft Market?
What are the emerging trends and future prospects in the global Coronary Artery Bypass Graft Market?

Competitive Intelligence and Business Strategy:

Key players in the Coronary Artery Bypass Graft (CABG) industry, including Terumo Corporation, Abbott Laboratories, and Medtronic plc, maintain market dominance through diverse strategies. Medtronic, as a multinational corporation, focuses on comprehensive cardiovascular care solutions, investing heavily in research and development for cutting-edge technologies like minimally invasive and robotic-assisted procedures. The company's global presence enables strategic alliances with healthcare establishments, ensuring widespread dissemination of CABG-related products. These industry leaders secure and expand their market share through innovation, international reach, and strategic partnerships, adapting to evolving healthcare demands.

Key Companies Profiled:

Teleflex Incorporated
B. Braun Melsungen AG
Smiths Medical (ICU Medical Inc.)
Becton, Dickinson and Company
Cardinal Health
Redax S.p.A.
Merit Medical Systems
Getinge AB
Rocket Medical plc.
Grena Ltd.
Sterimed Group
pfm medical ag
Medela AG
Sinapi Biomedical
ATMOS MedizinTechnik GmbH & Co. KG

Coronary Artery Bypass Graft Market Segmentation:

By Technology:

Off-pump CABG
On-pump CABG
Others

By Procedure:

Single CABG surgery
Double CABG surgery
Triple CABG surgery
Quadruple CABG surgery
Others

By End User:

Hospitals
Cardiology Clinics
Research Institutes
Others

By Region:

North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Product Code: PMRREP33856

1. Executive Summary

1.1. Global Coronary Artery Bypass Graft Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Technology Lifecycle Analysis
2.4. Coronary Artery Bypass Graft Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape

3. Global Coronary Artery Bypass Graft Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2013-2016
- 3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Coronary Artery Bypass Graft Market Outlook: Technology
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Technology, 2018 - 2022
- 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
  - 3.3.3.1. Off-pump CABG
  - 3.3.3.2. On-pump CABG
  - 3.3.3.3. Others
3.4. Market Attractiveness Analysis: Technology
3.5. Global Coronary Artery Bypass Graft Market Outlook: Procedure
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Procedure, 2018 - 2022
- 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Procedure, 2023 - 2030
  - 3.5.3.1. Single CABG surgery
  - 3.5.3.2. Double CABG surgery
  - 3.5.3.3. Triple CABG surgery
  - 3.5.3.4. Quadruple CABG surgery
  - 3.5.3.5. Others
3.6. Market Attractiveness Analysis: Procedure
3.7. Global Coronary Artery Bypass Graft Market Outlook: End User
- 3.7.1. Introduction / Key Findings
- 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
- 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  - 3.7.3.1. Hospitals
  - 3.7.3.2. Cardiology Clinics
  - 3.7.3.3. Research Institutes
  - 3.7.3.4. Others
3.8. Market Attractiveness Analysis: End User

4. Global Coronary Artery Bypass Graft Market Outlook: Region

4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia and Oceania
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region

5. North America Coronary Artery Bypass Graft Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 5.3.1. By Country
- 5.3.2. By Technology
- 5.3.3. By Procedure
- 5.3.4. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 5.4.1. U.S.
- 5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
- 5.5.1. Off-pump CABG
- 5.5.2. On-pump CABG
- 5.5.3. Others
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Procedure, 2023 - 2030
- 5.6.1. Single CABG surgery
- 5.6.2. Double CABG surgery
- 5.6.3. Triple CABG surgery
- 5.6.4. Quadruple CABG surgery
- 5.6.5. Others
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 5.7.1. Hospitals
- 5.7.2. Cardiology Clinics
- 5.7.3. Research Institutes
- 5.7.4. Others
5.8. Market Attractiveness Analysis

6. Europe Coronary Artery Bypass Graft Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 6.3.1. By Country
- 6.3.2. By Technology
- 6.3.3. By Procedure
- 6.3.4. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Turkiye
- 6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
- 6.5.1. Off-pump CABG
- 6.5.2. On-pump CABG
- 6.5.3. Others
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Procedure, 2023 - 2030
- 6.6.1. Single CABG surgery
- 6.6.2. Double CABG surgery
- 6.6.3. Triple CABG surgery
- 6.6.4. Quadruple CABG surgery
- 6.6.5. Others
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 6.7.1. Hospitals
- 6.7.2. Cardiology Clinics
- 6.7.3. Research Institutes
- 6.7.4. Others
6.8. Market Attractiveness Analysis

7. East Asia Coronary Artery Bypass Graft Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 7.3.1. By Country
- 7.3.2. By Technology
- 7.3.3. By Procedure
- 7.3.4. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
- 7.5.1. Off-pump CABG
- 7.5.2. On-pump CABG
- 7.5.3. Others
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Procedure, 2023 - 2030
- 7.6.1. Single CABG surgery
- 7.6.2. Double CABG surgery
- 7.6.3. Triple CABG surgery
- 7.6.4. Quadruple CABG surgery
- 7.6.5. Others
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 7.7.1. Hospitals
- 7.7.2. Cardiology Clinics
- 7.7.3. Research Institutes
- 7.7.4. Others
7.8. Market Attractiveness Analysis

8. South Asia & Oceania Coronary Artery Bypass Graft Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 8.3.1. By Country
- 8.3.2. By Technology
- 8.3.3. By Procedure
- 8.3.4. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
- 8.5.1. Off-pump CABG
- 8.5.2. On-pump CABG
- 8.5.3. Others
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Procedure, 2023 - 2030
- 8.6.1. Single CABG surgery
- 8.6.2. Double CABG surgery
- 8.6.3. Triple CABG surgery
- 8.6.4. Quadruple CABG surgery
- 8.6.5. Others
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 8.7.1. Hospitals
- 8.7.2. Cardiology Clinics
- 8.7.3. Research Institutes
- 8.7.4. Others
8.8. Market Attractiveness Analysis

9. Latin America Coronary Artery Bypass Graft Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 9.3.1. By Country
- 9.3.2. By Technology
- 9.3.3. By Procedure
- 9.3.4. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
- 9.5.1. Off-pump CABG
- 9.5.2. On-pump CABG
- 9.5.3. Others
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Procedure, 2023 - 2030
- 9.6.1. Single CABG surgery
- 9.6.2. Double CABG surgery
- 9.6.3. Triple CABG surgery
- 9.6.4. Quadruple CABG surgery
- 9.6.5. Others
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 9.7.1. Hospitals
- 9.7.2. Cardiology Clinics
- 9.7.3. Research Institutes
- 9.7.4. Others
9.8. Market Attractiveness Analysis

10. Middle East & Africa Coronary Artery Bypass Graft Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 10.3.1. By Country
- 10.3.2. By Technology
- 10.3.3. By Procedure
- 10.3.4. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technology, 2023 - 2030
- 10.5.1. Off-pump CABG
- 10.5.2. On-pump CABG
- 10.5.3. Others
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Procedure, 2023 - 2030
- 10.6.1. Single CABG surgery
- 10.6.2. Double CABG surgery
- 10.6.3. Triple CABG surgery
- 10.6.4. Quadruple CABG surgery
- 10.6.5. Others
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 10.7.1. Hospitals
- 10.7.2. Cardiology Clinics
- 10.7.3. Research Institutes
- 10.7.4. Others
10.8. Market Attractiveness Analysis

11. Competition Landscape

11.1. Market Share Analysis, 2022
11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Analog IC
- 11.2.3. Apparent Technology Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. Teleflex Incorporated
  - 11.3.1.1. Overview
  - 11.3.1.2. Segments and Technology
  - 11.3.1.3. Key Financials
  - 11.3.1.4. Market Developments
  - 11.3.1.5. Market Strategy
- 11.3.2. B. Braun Melsungen AG
  - 11.3.2.1. Overview
  - 11.3.2.2. Segments and Technology
  - 11.3.2.3. Key Financials
  - 11.3.2.4. Market Developments
  - 11.3.2.5. Market Strategy
- 11.3.3. Smiths Medical (ICU Medical Inc.)
  - 11.3.3.1. Overview
  - 11.3.3.2. Segments and Technology
  - 11.3.3.3. Key Financials
  - 11.3.3.4. Market Developments
  - 11.3.3.5. Market Strategy
- 11.3.4. Becton, Dickinson and Company
  - 11.3.4.1. Overview
  - 11.3.4.2. Segments and Technology
  - 11.3.4.3. Key Financials
  - 11.3.4.4. Market Developments
  - 11.3.4.5. Market Strategy
- 11.3.5. Cardinal Health
  - 11.3.5.1. Overview
  - 11.3.5.2. Segments and Technology
  - 11.3.5.3. Key Financials
  - 11.3.5.4. Market Developments
  - 11.3.5.5. Market Strategy
- 11.3.6. Redax S.p.A.
  - 11.3.6.1. Overview
  - 11.3.6.2. Segments and Technology
  - 11.3.6.3. Key Financials
  - 11.3.6.4. Market Developments
  - 11.3.6.5. Market Strategy
- 11.3.7. Merit Medical Systems
  - 11.3.7.1. Overview
  - 11.3.7.2. Segments and Technology
  - 11.3.7.3. Key Financials
  - 11.3.7.4. Market Developments
  - 11.3.7.5. Market Strategy
- 11.3.8. Getinge AB
  - 11.3.8.1. Overview
  - 11.3.8.2. Segments and Technology
  - 11.3.8.3. Key Financials
  - 11.3.8.4. Market Developments
  - 11.3.8.5. Market Strategy
- 11.3.9. Rocket Medical plc.
  - 11.3.9.1. Overview
  - 11.3.9.2. Segments and Technology
  - 11.3.9.3. Key Financials
  - 11.3.9.4. Market Developments
  - 11.3.9.5. Market Strategy
- 11.3.10. Grena Ltd.
  - 11.3.10.1. Overview
  - 11.3.10.2. Segments and Technology
  - 11.3.10.3. Key Financials
  - 11.3.10.4. Market Developments
  - 11.3.10.5. Market Strategy
- 11.3.11. Sterimed Group
  - 11.3.11.1. Overview
  - 11.3.11.2. Segments and Technology
  - 11.3.11.3. Key Financials
  - 11.3.11.4. Market Developments
  - 11.3.11.5. Market Strategy
- 11.3.12. pfm medical ag
  - 11.3.12.1. Overview
  - 11.3.12.2. Segments and Technology
  - 11.3.12.3. Key Financials
  - 11.3.12.4. Market Developments
  - 11.3.12.5. Market Strategy
- 11.3.13. Medela AG
  - 11.3.13.1. Overview
  - 11.3.13.2. Segments and Technology
  - 11.3.13.3. Key Financials
  - 11.3.13.4. Market Developments
  - 11.3.13.5. Market Strategy
- 11.3.14. Sinapi Biomedical
  - 11.3.14.1. Overview
  - 11.3.14.2. Segments and Technology
  - 11.3.14.3. Key Financials
  - 11.3.14.4. Market Developments
  - 11.3.14.5. Market Strategy
- 11.3.15. ATMOS MedizinTechnik GmbH & Co. KG
  - 11.3.15.1. Overview
  - 11.3.15.2. Segments and Technology
  - 11.3.15.3. Key Financials
  - 11.3.15.4. Market Developments
  - 11.3.15.5. Market Strategy

12. Appendix

12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations